NIH Director’s Early Independence Awards (DP5 Clinical Trial optional)

 

Internal Submission Deadline:  Monday, July 11, 2022

Internal Submission application linkhttps://unthsc.infoready4.com/#competitionDetail/1872582

Letter of Intent Due: Tuesday, August 2, 2022

Funding Organization’s Deadline: Friday, September 2, 2022

Award Budget: Awards will be for up to $250,000 in direct costs per year, plus applicable Facilities and Administrative (F&A) costs.

Number of applications: Only two applications per institution (normally identified by having a Unique Entity Identifier (UEI) number or NIH IPF number) are allowed.

 

Limited submission opportunities are those for which the agencies restrict the number of proposals or nominations a university may submit for consideration for an award. Extra submissions can result in rejection of all submitted by the institution. Therefore, all eligible and interested nominees must be internally screened to determine which will represent the university in the agency’s competition. This application is for the nomination from our institution.

The NIH Director’s Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement.

In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director’s Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Please visit the sponsor’s website for complete information, rules and eligibility

For each competition, principal investigators are required to submit a limited submission pre-proposal by the internal deadline specified in the announcement. The pre-proposal should address the sponsoring agency’s priorities as outlined in the announcement.

The pre-proposal should be no more than 3 pages in length in 11-point font with 0.5” margins and must contain the following information:

  • Proposal title
  • Principal Investigator and Co-Principal Investigator(s), Department and College
  • Proposed start date and duration of the project
  • Estimated (total) budget for the entire performance period
  • Summary of the project (main body of the document)

The limited submission committee will convene to review the pre-proposals following review guidelines. The committee will provide a recommendation to the Vice President of Research who makes the final decision regarding the internal competition.